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Objective: This study was designed to determine whether either of 2 alternative
methods of extracardiac Fontan reconstruction provides superior results.
Methods: We reviewed 58 consecutive Fontan procedures performed between 1995
and 2001 with a pedicled pericardial tunnel (group P, n  21) or an extracardiac
conduit of polytetrafluoroethylene or allograft aorta (group C, n  37). Operations
were performed with cardiopulmonary bypass at 32°C; an aortic crossclamp was
applied in only 6 patients. All group P patients and 33 (89%) group C patients
received fenestrations.
Results: The groups were similar in terms of age, weight, anatomy, and preoperative
hemodynamics. There were 3 hospital deaths (5%; 70% confidence limit, 2%-30%),
all in group C. Median durations of mechanical ventilation (group P, 1 day; group
C, 1 day), intensive care unit stay (group P, 3 days; group C, 3 days), chest tube
drainage (group P, 8 days; group C, 7 days), and hospitalization (group P, 10 days;
group C, 9 days) were not significantly different. There were no late deaths. All
patients received warfarin sodium, and there were no late strokes. Before the Fontan
procedure, 1 patient in group P and 3 patients in group C required pacemaker
implants. Of the 51 surviving patients in sinus rhythm before the Fontan procedure,
only 1 patient in group C subsequently required a pacemaker.
Conclusions: Extracardiac Fontan procedures with either a pericardial baffle or
conduit are associated with low operative mortality and low risks of arrhythmia and
late thromboembolic complication.
Efforts to improve the circulatory function of patients with single-ventricle physiology have focused on characteristics such as flowdynamics, thrombogenicity, atrial incisions and suture lines, growthpotential, and ease of surgical reconstruction, resulting in severalmodifications of the original Fontan procedure.1-3 The widely usedextracardiac total cavopulmonary connection with a synthetic con-
duit or homograft can be constructed without cardiac ischemia or large atrial
incisions and has performed well in several large series.2-6 The use of pedicled
pericardium for the extracardiac connection is a more recent modification with
additional potential advantages. Gundry and colleagues7 observed good flow char-
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acteristics and growth of the connection in a series of 19
patients. Growth potential is theoretically a significant ad-
vantage because a large proportion of total cavopulmonary
connection procedures are now performed in children be-
fore age 2 to 3 years. Pedicled pericardium might also have
a lesser tendency for infectious and thromboembolic com-
plications. However, experience with pedicled pericardial
reconstruction is limited and has not been compared with
reconstruction with synthetic conduits or allograft vessels in
a contemporary series.
This study reviews an experience with extracardiac Fon-
tan repairs initiated in 1995. Pedicled pericardium was,
from the beginning, adopted as the technique of choice.
Prosthetic or allograft conduits also were used, usually
because of unfavorable anatomy or lack of pericardium. The
2 types of reconstruction used in this series were compared
with respect to both immediate and longer-term outcomes.
Patients and Methods
Patient Population
The medical records of all patients undergoing a Fontan procedure
from January 1, 1995, through December 31, 2001, at a single
children’s hospital were reviewed. Before 1995, all Fontan proce-
dures performed within this institution were some variety of in-
tracardiac operations. Beginning in 1995, the extracardiac Fontan
procedure was used exclusively. Demographic information, car-
diac anatomy, pre-Fontan operative and nonoperative treatment,
operative details, and postoperative outcomes were recorded. Pa-
tients, families, cardiologists, and primary care physicians were
contacted when necessary to acquire current follow-up informa-
tion. Permission for performance of this study was obtained from
the institutional review board.
Operative Techniques
Extracardiac Fontan reconstruction with a pedicled pericardial
baffle, as described by Gundry and associates,7 was considered the
preferred operative approach. This method was undertaken for all
patients whose congenital anatomy permitted this procedure and
whose pericardium was adequate for the purpose. The operative
technique included the use of cardiopulmonary bypass with mod-
erate hypothermia (32°C). Cannulation of the aorta and the supe-
rior vena cava was performed in standard fashion. On bypass, the
inferior vena cava was clamped at its junction with the right
atrium, and the anterolateral wall of the inferior vena cava was
incised. The proximal junction of the cava and the atrium was
oversewn with a 5-0 polypropylene suture, closing the atrium and
allowing removal of the clamp. The inferior vena cava was not
cannulated; rather return of inferior vena caval blood to the bypass
circuit was accomplished with cardiotomy suction. The pericar-
dium on the systemic venous side was mobilized, with care taken
not to damage the phrenic nerve. The pericardium was incised at
its superior extent in a perpendicular direction toward the superior
vena cava and at its inferior extent toward the inferior vena cava.
The posteromedial aspect of the pericardium remained attached,
allowing the pericardium to assume a hemicylindrical shape, with
the atrial free wall as its floor. The inferior margin of the pericar-
dium was sewn to the edge of the partially divided inferior vena
cava, and this suture line was continued for a short distance onto
the atrial free wall. The distal pulmonary arteries were then con-
trolled, and a pulmonary arteriotomy was performed. The posterior
wall of the opened pulmonary artery was sewn to the dome of the
atrium. The superior margin of the pericardial baffle was sewn to
the anterior wall of the pulmonary artery, and this suture line was
also continued onto the atrial free wall. The suture lines from the
superior and inferior ends were then continued toward each other.
An effort was made to place all sutures on the atrial free wall in a
superficial fashion and to avoid any full-thickness suture lines. Just
before completion of the atrial suture line, a 5-mm fenestration
between the pericardial baffle and the lumen of the atrium was
created with a punch. There was no attempt made to adjust the size
of the fenestration on the basis of patient size or other consider-
ations.
When the pericardium was inadequate to permit a baffle con-
struction or when congenital anomalies required a more compli-
cated routing of inferior vena caval blood, an extracardiac conduit
was used for the Fontan repair. As for the baffle reconstruction,
cardiopulmonary bypass with moderate hypothermia was used.
The inferior vena cava was divided, and an end-to-end anastomosis
was performed with a conduit. Initial patients received an allograft
aortic conduit; subsequent patients received a conduit of expanded
polytetrafluoroethylene (PTFE).* The other end of the conduit was
anastomosed to the pulmonary artery. The caliber of the PTFE tube
(or allograft) was 16 to 18 mm on the basis of the measured caliber
of the inferior vena cava. A fenestration, if used, was performed by
creating parallel 5- to 6-mm holes in the PTFE tube and the atrial
free wall and anastomosing them with 5-0 PTFE sutures.
If patients required an additional intracardiac procedure, per-
fusate temperatures were reduced to 27°C, and cardioplegic arrest
was performed before the Fontan repair. In all other cases not
requiring intracardiac procedures, the aorta was not crossclamped,
and the myocardium was perfused throughout the operation. This
required particular attention to avoid air emboli.
Routine monitoring included a superior vena caval catheter,
usually placed percutaneously after induction of anesthesia, and an
atrial catheter placed intraoperatively.
Statistical Analysis
Mean values and SDs were calculated for continuous variables.
Comparisons were made between patients who underwent the
Fontan procedure with the extracardiac pericardial baffle and those
who received an extracardiac conduit. All analyses were per-
formed with StatView statistical software (Abacus Concepts,
Berkeley, Calif).
Results
Operative Details and Patient Characteristics
During the 7-year period from 1995 to 2001, there were 58
Fontan procedures performed. Of these, a pedicled pericar-
dial baffle was performed in 21 patients, and an extracardiac
conduit was performed in 37 patients. Fenestrations were
performed at the time of the Fontan procedure in all patients
*Gore-Tex; registered trademark of W. L. Gore & Associates, Inc, Flagstaff,
Ariz.
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undergoing a pericardial baffle and in 32 (86%) patients
having an extracardiac conduit. Conduits used were aortic
allografts in 4 patients and PTFE conduits in 33 patients. In
addition to the Fontan procedure, other procedures were
performed in 2 patients who underwent a pericardial baffle
(1 repair of an insufficient atrioventricular valve and 1 atrial
septectomy) and 6 patients who received a conduit (2 re-
pairs of insufficient atrioventricular valves, 2 atrial septec-
tomies, 1 resection for subaortic stenosis, and 1 transloca-
tion of an anomalous coronary artery). Cardiac arrest times
for these 8 patients ranged from 11 to 66 minutes (mean,
35  21 minutes).
Patient ages in the pericardial baffle group (mean, 38 
14 months; median, 37 months) and in the conduit group
(mean, 46  28 months; median, 40 months) were not
significantly different. Patient weights in the pericardial
group (mean, 13.2  1.8 kg; median, 12.9 kg) and in the
conduit group (mean, 15.4  6.0 kg; median, 14.0 kg) also
were not significantly different.
Congenital cardiac defects are displayed in Table 1. The
largest single group of cardiac diagnoses was hypoplastic
left heart syndrome, which occurred in almost a third of the
overall patient population. In the pericardial baffle group the
dominant ventricle exhibited left ventricular morphology in
13 patients and right ventricular morphology in 8 patients.
Among the extracardiac conduit group, the dominant ven-
tricle was of left ventricular morphology in 20 patients and
right ventricular morphology in 17 patients. First-stage pal-
liations are shown in Table 2. Consistent with the anatomic
diagnoses, systemic–pulmonary artery shunts and the Nor-
wood operation were the most common initial operations.
Eleven patients, however, did not have a typical first-stage
operation because of balanced systemic and pulmonary
flow.
All patients, regardless of initial palliation or lack
thereof, underwent a bidirectional Glenn procedure at age 4
months to 7 years (mean, 13.1  13.6 months; median, 8.7
months). The bidirectional Glenn procedure was accompa-
nied by additional operative procedures in 9 patients: 3
unifocalizations of discontinuous pulmonary arteries, 2
atrial septectomies, 1 Damus-Kaye-Stansel procedure, 1
pulmonary arterioplasty, 1 tricuspid valvuloplasty, and 1
pacemaker insertion.
Perioperative Morbidity and Mortality
There were 3 (5%; 70% confidence limit, 2%-30%) in-
hospital deaths. All deaths occurred in the conduit group,
and all of these patients had a fenestration. One death was
due to an air embolus occurring during cardiopulmonary
bypass. A second death occurred in a patient with severe
heart failure before the Fontan procedure. The patient was
successfully extubated and managed for a period of time but
died on postoperative day 35 with persistent heart failure.
The third death occurred in a patient with increased pulmo-
nary vascular resistance who died on postoperative day 6. In
retrospect, this patient might have survived had the Fontan
repair been taken down. Thus in no case did the use of the
conduit, as opposed to the pericardial baffle, appear to have
influenced mortality. The patients who died did not have
preoperative cardiac catheterization measurements that
might have predicted a more difficult course. In each case
the measured pressures and calculated resistances were
within the usual range of acceptability for this operation.
One additional patient with increased pulmonary resistance
who underwent a PTFE conduit repair underwent takedown
of the repair on postoperative day 1 and survived.
Seven additional surviving patients had important com-
plications. One patient with a nonfenestrated PTFE conduit
had low cardiac output and ascites but responded success-
fully to operative revision and creation of a fenestration.
Four patients (2 with aortic allografts, 1 with a PTFE
conduit, and 1 with a pericardial baffle) were found to have
had mild strokes, as indicated by a computed tomographic
scan. The ages of the strokes were not always clear, and it
was not possible to determine whether these events occurred
in the immediate perioperative period or had preceded the
operations by some length of time. All of these patients had
good recovery, with minimal or no sequelae. Two patients
TABLE 1. Congenital cardiac anatomy
Pericardial baffle (n  21)
Hypoplastic left-heart syndrome 7
Tricuspid atresia 5
Pulmonary atresia–intact septum 4
Unbalanced atrioventricular septal defect 2
Double-inlet left ventricle 2
Double-outlet right ventricle 1
Extracardiac conduit (n  37)
Hypoplastic left-heart syndrome 11
Unbalanced atrioventricular septal defect 6
Double-inlet left ventricle 6
Tricuspid atresia 5
Pulmonary atresia–intact septum 5
Double-outlet right ventricle 3
Ebstein malformation 1
TABLE 2. Stage 1 operative procedures
Pericardial baffle (n  21)
Norwood procedure 8
Systemic-pulmonary shunt 7
Pulmonary artery band 1
No stage 1 procedure 5
Extracardiac conduit (n  37)
Systemic-pulmonary shunt 18
Norwood procedure 11
Pulmonary artery band 3
No stage 1 procedure 5
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(1 with a pericardial baffle and 1 with a PTFE conduit) had
mediastinitis that required operative debridement and repair
of the chest wall without revision of the cardiac reconstruc-
tion. Despite the use of cardiotomy suction for the inferior
vena caval return, hemolysis did not appear to be an impor-
tant problem.
Hospital Course
For all patients who were hemodynamically stable, efforts
were made to extubate at the earliest possible time postop-
eratively. The median duration of mechanical ventilation in
hospital survivors was 1 day in each group. The median
duration of intensive care unit hospitalization among survi-
vors was 3 days in each group. The median duration of chest
tube drainage was 7 days in the pericardial baffle group and
8 days in the conduit group. The median duration of total
hospital stay was 9 days in each group. None of these
differences is statistically significant.
Follow-up and Late Results
Information regarding the late status of patients was ob-
tained from medical records, office records of cardiologists
and primary care physicians, and personal contact with
patients and families. Follow-up during calendar year 2001
was accomplished for 49 (89%) of 55 patients surviving
hospitalization. Mean duration of follow-up was 23 months.
Overall follow-up was 88.6% complete. There were no late
deaths. Three patients underwent late reoperations: 1 patient
with a pericardial baffle received a pleurectomy for recur-
rent pleural effusions, 1 patient with a conduit received a
pericardial window for recurrent pericardial effusions, and 1
patient with a conduit received a diaphragm plication for
diaphragm paralysis.
All patients were started on warfarin sodium (Coumadin)
beginning on postoperative day 2, with a goal of achieving
an international normalized ratio of 1.5 to 2.0. Heparin and
antiplatelet agents were not used. The duration of continu-
ing warfarin sodium was left to the discretion of the pa-
tient’s personal cardiologist; however, it was recommended
that warfarin sodium be continued indefinitely when com-
pliance could be predicted and there were no contraindica-
tions. There was no intention of selectively using warfarin
therapy on the basis of the type of Fontan modification,
presence or absence of a fenestration, cardiac rhythm, or
other factors.
Patients were otherwise free of any other late complica-
tions sometimes associated with the Fontan procedure. Spe-
cifically, no patients had protein-losing enteropathy, and
there were no late strokes or other clinical events consistent
with cerebral emboli, no other systemic embolic events, no
hemorrhagic complications, and no pulmonary venous com-
plications.
Electrocardiographic Results
Electrocardiographic results were based on 12-lead electro-
cardiograms and selective use of Holter monitors, as clini-
cally indicated. Pacemakers had been implanted in 5 pa-
tients before undergoing the Fontan procedure or
concomitantly with the Fontan procedure. Of the 19 patients
who underwent pericardial baffle repair and who were in
sinus rhythm before the Fontan procedure, all remain in
sinus rhythm at an acceptable rate at the time of their latest
electrocardiogram 2 to 73 months postoperatively (mean, 15
months). Among the 31 patients who were in sinus rhythm
at the time of their extracardiac conduit Fontan procedure
and survived operation, 30 remain in sinus rhythm 2 to 69
months postoperatively (mean, 26 months). The remaining
patient with conduits required a pacemaker for sinus brady-
cardia.
Patency of Fenestrations
Among the 21 patients who had a pericardial baffle, all of
whom had fenestrations placed intraoperatively, 3 fenestra-
tions were closed with catheter-delivered closure devices
because of excessive right-to-left shunting, 4 closed spon-
taneously, and 14 remain patent, as determined by means of
echocardiography. Among the 29 surviving patients who
had fenestrations with an extracardiac conduit Fontan pro-
cedure, 1 underwent transcatheter closure, 1 underwent sur-
gical closure, 12 underwent spontaneous closure, and 15
remain patent.
Discussion
Pericardium has been used in a variety of cardiovascular
reconstructive procedures. Its use in constructing a cavo-
pulmonary connection was first described in 1992 by Hvass
and associates,8 who constructed a tube of pericardium to
connect the inferior vena cava to the pulmonary artery.
Other reports describe Fontan constructions with only au-
tologous tissue by using native atrial wall and septum or
unusually located inferior cavae.9-10 In 1997, Gundry and
colleagues7 reported their series of extracardiac pericardial
reconstructions, in which pericardium was attached to the
lateral wall of the right atrium or the interatrial groove to
connect the inferior vena cava to the pulmonary artery. Of
19 patients, there were no operative deaths or subsequent
complications of thromboembolism or arrhythmia. More-
over, follow-up studies confirmed growth of the pathway.
The current series includes patients who had extracardiac
Fontan procedures on the basis of the approach of Gundry
and colleagues,7 as well as a contemporaneous group un-
dergoing repair with extracardiac synthetic conduits. A
comparison of these alternative techniques within a single
institution by surgeons whose approach is otherwise con-
sistent has not been previously reported. An evaluation of
routine clinical parameters revealed that both types of re-
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constructions were associated with low mortality, short
length of stay, acceptable duration of pleural drainage, and
few longer-term complications, with follow-up extending
beyond 6 years in both groups. Longer-term follow-up
might reveal advantages related to the growth potential of
the pericardial reconstruction. In the present study there is
not documentation of growth. In part this relates to the
difficulty in retrospective analysis of the patients’ echocar-
diographic studies. In the absence of uniform techniques,
personnel, and measurement strategies, consistent measure-
ments might be lacking, and data on the basis of these sites
are of dubious validity.
Pathway construction with pedicled pericardium can be
somewhat more technically demanding. In a high percent-
age of patients in this series, the pericardium was unavail-
able or of inadequate integrity for the reconstruction. In no
patient in this series was an insufficient quantity of pericar-
dium augmented with contralateral pericardium or pros-
thetic tissue. Had that been done, it might have been pos-
sible to reduce the frequency of conduit repair. Also
technically challenging is the complicated anatomic rela-
tionship commonly observed in patients with heterotaxy
syndrome. In these patients the remoteness of the inferior
vena cava can increase the challenges of a pericardial baffle.
All heterotaxic patients in this series had a conduit repair.
Regardless of the type of extracardiac approach, reconstruc-
tion can be performed without cardiac ischemia and with
bypass times that are similar to those of other techniques.
Yet another technical issue is injury to the phrenic nerve.
This problem is sometimes encountered in other modifica-
tions of the Fontan procedure as well, but this was observed
in only one patient in this series.
The relative merits of the flow properties of these alter-
native pathways are unknown. It is possible that the pliabil-
ity of the pericardial baffle degrades efficiency of energy
transfer along the pathway. However, this pliability also
allows transmission of intrathoracic pressure and respiratory
variation, which might ultimately provide greater enhance-
ment of flow.7,11 Patients in this series underwent echocar-
diographic and angiographic evaluations that have revealed
low velocity flow without significant turbulence through
either the pericardial baffle or the extracardiac conduit.
Clinical parameters, such as oxygen saturation, cardiac out-
put, pleural fluid drainage, ascites, and enteropathy, al-
though quite indirect measures of hemodynamic perfor-
mance, did not differ significantly between the 2 types of
reconstructions in this series.
The almost uniform use of a fenestration in this series is
one difference from the series of Gundry and colleagues.7
The use of the fenestration was favored because it appeared
to reduce the perioperative instability in patients undergoing
Fontan procedures with only a minimal reduction in arterial
saturation. The fenestration also appeared to benefit some
patients in the longer term by helping to maintain a more
adequate cardiac output. The routine use of a fenestration
has resulted in a small number of patients who have re-
quired later closure of this fenestration because of excessive
desaturation. In most cases the fenestration closes sponta-
neously or remains patent without adverse effects. The
patency rate of fenestrations and the need for fenestration
closure were similar in the pericardial and conduit groups.
All patients in this series, regardless of the type of
material used for the reconstruction, were treated with war-
farin because of the prothrombotic tendency of the Fontan
circulation.12,13 It might be speculated that a pericardial
baffle is at lower risk of thrombus formation than a pros-
thetic conduit. However, other variables, such as caliber of
the connection, volume of flow, pulmonary artery capaci-
tance, and cardiac function, might be stronger influences on
the thromobotic potential of the Fontan connection. The
small number of patients and thromboembolic events in this
series preclude a meaningful conclusion as to the superiority
of one approach over the other.
Five children in this series ultimately received pacemak-
ers: 3 were implanted before the Fontan procedure, and 1
was implanted in each of the 2 groups after the Fontan
procedure. Although atrial incisions, and perhaps suture
lines, might promote arrhythmias, most authors recognize
the cumulative effects of multiple procedures, dissections in
the area of the sinoatrial node, and hemodyamic factors in
the genesis of arrhythmias.14-16 The current data indicate
that both types of Fontan procedure have a low frequency of
arrhythmias within the time frame of this review. The long
lag time between Fontan procedures and the subsequent
development of arrhythmias, however, indicates that cau-
tion should be exercised in drawing conclusions regarding
the ultimate arrhythmogenicity of these techniques.
Limitations of the present study include the relatively
small numbers of patients in the 2 groups and the lack of
randomization. The more complicated anatomy in the con-
duit group, taken as a whole, probably biases the results
against this technique. In addition, it is recognized that
many of the complications of the Fontan operation and its
modifications occur many years after the procedure. Pro-
tein-losing enteropathy and arrhythmias are perhaps the 2
most dangerous late sequelae that rarely occur within the
first 5 years after the Fontan procedure.
From these data, it is concluded that either pedicled
pericardium or synthetic conduits can be used for construct-
ing the extracardiac Fontan repair, with no significant dif-
ferences in clinical performance, mortality, or complica-
tions. It will be important to maintain longer follow-up
periods to determine whether the growth potential of pedi-
cled pericardium is realized and whether either approach
over additional years affects rhythm disturbances, thrombo-
embolic events, and length and quality of life.
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Discussion
Dr Steven R. Gundry (Palm Springs, Calif). I congratulate the
authors on their study comparing the pericardial lateral tunnel that
bears my name with an extracardiac prosthetic lateral tunnel. It is
said that an inventor of an operation can hopefully achieve great
results, but it is only until these results are achieved by others that
any new operation should be taken seriously. I thank you for your
article from the bottom of my pericardium.
I will not summarize the authors’ results because they have
been shown so well today. Rather, I will concentrate on those areas
where the authors’ techniques differ from our experience at Loma
Linda and now at the International Heart Institute of Palm Springs.
The authors state that although the pericardial lateral tunnel is
their preferred technique, it could only be used in 35% of their
patients because of an absence of adequate pericardium or the
presence of complex anatomy. In our experience we have not had
to resort to prosthetic extracardiac devices, even in cases of com-
plex anatomy and complex tunneling, often using the pericardial
tunnel beneath the free left ventricle and complex anatomy or
supplementing inadequate pericardium from one side with pericar-
dium taken from the other side. Our late results continue to support
this approach. Although you mention reasons in your article, why
did you abandon your preferred approach in the majority of pa-
tients for a prosthetic conduit?
Dr Woods. This is the teacher talking to the ultimate author. If
your experience with doing that is showing good results, then I
think Dr Lupinetti or I would consider trying it. Part of that low
instance reflects the patient population in some degree also in that
if you are having a triply staged pathway, then you are going to be
more in the chest and with lesser qualities of pericardium for your
final stage. The ultimate thing that guided the operations in these
cases was brevity and simplicity. If the procedure was going to
entail a more detailed pericardial reconstructive technique, then it
was abandoned.
Dr Gundry. Good answer. You used fenestrations in all of
your patients, a technique that we abandoned in 1992. I note that
you did have a 7% stroke rate and that 10% of your patients have
required subsequent intervention for closure of the fenestration,
both catheter based and surgical, and that all your patients had to
take warfarin. What do you think are the reasons why you would
continue to use these techniques that support fenestrations in light
of the significant morbidity associated with fenestrations?
Dr Woods. We have not documented any specific fenestration-
related morbidity. The use of warfarin was purely elective at the
outset of the series on the basis of work by others. In terms of the
strokes that occurred, 3 of those actually occurred in children in
whom PTFE was used for reconstruction. Only 1 occurred in a
child with a fenestration, and therefore it is hard for us to attribute
that to fenestration-passage thromboembolic material. In our ex-
perience it is anecdotal but it seems that—and in discussing this
with the interventional cardiologist before I left Seattle who does
our fenestration closure—the children seem to be getting out of the
hospital more quickly with less effusion and less time to resump-
tion of normal function, but it is certainly a matter of choice
involved, as well as objectivity.
Dr Gundry. This actually brings me to my final question. Your
time to discharge is a median of 9 days. That does not seem cost
effective. It seems to be related to chest tube drainage time.
Beginning in 1994, as you might know, we began sending patients
home with Blake drains in place and actually teaching the mothers
to empty these. My partner, Leonard Bailey, currently holds the
record for a first-postoperative-day discharge using this technique,
while I pale to his series with a second-postoperative-day dis-
charge in the majority of my cases. Have you considered using
Blake drains to speed earlier discharge?
Dr Woods. That has been done in a limited fashion in the more
recent months. Of course, much depends on your referral popula-
tion and your comfort level. With referrals that are across state
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lines, we are a little less comfortable doing that, but with local
referrals we do occasionally use early discharge.
Dr Gregory Fontana (Los Angeles, Calif). I would like to
compliment the authors as well on a fantastic series. We continue
the search for the holy grail along the Fontan pathway. Certainly,
we are not near the end.
I am concerned about any sort of atrial incisions. In many
clinical series the most significant long-term morbidity after a
Fontan procedure is atrial arrhythmias. In laboratory studies vari-
ous atrial incisions or suture lines have been shown to augment the
substrate of atrial arrhythmias. Clearly, there are some theories of
the pedicled periventricular tunnel to the prosthetic external con-
duit; however, I am concerned about the potential risk for devel-
opment of atrial arrhythmias caused by the pericardial pedicle.
Dr Woods. I fully share your concerns. We await further
follow-up. As you know, the studies that have looked at that have
shown that it is a multifactorial process. It does not just necessarily
relate to incisions or suture lines in the area but also hemodynamic
factors, the number of times you go back in. Peter Manning
published a study in the last couple of years demonstrating that the
causes are multifactorial. I guess partial thickness in suture lines
will have some role, but that is not an objective view either. We
share your concerns, but there are not enough objective data
proving the contrary, and therefore it seems feasible to at least
monitor these patients long term by electrocardiographic follow-
up.
Dr Fontana. What is your indication for the pedicle pericardial
technique? Is it for patients with unusual anatomy? Is it for the
smaller patient in whom you are hoping for some growth poten-
tial? Or is it on a case-by-case basis?
Dr Woods. As a general statement, each case is approached
with a preference to using pericardium. Of course, it is going to be
modified on an individual basis, and I think that in children who
have had maybe multiple re-entries for complications or something
like that, where their pericardium is subsequently of lesser quality,
there might be some selection bias involved with that. However, in
general, if the pericardium is there, if it can be dissected and
mobilized and it is not pitted with multiple areas of thinning, it will
be used whether the child is 4 or 6 or 12 kg.
Dr Fontana. Are you saying that the basis for this technique is
to achieve total autologous surfaces?
Dr Woods. Yes.
Dr Hillel Laks (Los Angeles, Calif). I also would like to
congratulate you on the excellent results. The proposed advantage
of the extracardiac conduit is that you have a rigid tube and
laminar flow. With the pericardial tube, I would assume that you
have a structure that is less tubular and more irregular. Have any
studies, such as magnetic resonance angiography through 3-dimen-
sional reconstruction, been done to look at the shape of these tubes
and how much turbulence you have? Also, with the issue of
follow-up echocardiograms in all of these patients, do you have
any evidence of areas of stenosis at the inferior vena caval orifice
with long-term follow-up, and what is the evidence that growth
occurs in your patients with the longest follow-up? Last, the
proposed advantage of lateral tunnel and natural tissue is of course
the lack of the use of anticoagulants. Why have you continued to
use anticoagulants long term in the patients receiving pericardial
tubes and have you had any experience with not using anticoagu-
lants in that group?
Dr Woods. Paranoia is pretty much the last factor. We can
discuss this with Dr Lupinetti, but the prothrombotic or altered
thrombotic state of these children is a known entity, and whether
you are using synthetic or native tissue, they are still existing in an
altered coagulation state. I think it is for that reason, combined
with a little bit of paranoia, that anticoagulation is still done. It
might be that in the future this will be stopped, but it is not
something that we have discussed at this point. Therefore, we
might be able to appreciate that advantage in the future.
In terms of the follow-up echocardiographic analysis, the actual
inferior portion in our series—and I would be interested to hear
what Dr Gundry’s series has shown—is actually quite patent and,
if anything, capacious. It is at the superior end, where the vein
comes underneath, that there is, if anything, relative appearance of
narrowing, although there are no gradients that we have been able
to pick up. We have used a stent in one child in our series, I
believe, since analysis of these data who had some narrowing in
that area.
In terms of flow analysis, that is something that is in an
institutional review board that is still in the process of being
submitted by using magnetic resonance to analyze flow in these
pathways. As you can imagine, locating children after a post–third
stage reconstruction and getting them to come back in is taking
some time. The only 2 magnetic resonance studies that I am aware
of that have looked at flow in Fontan pathways have been the ones
from Morgan in 1998 and Fogel in 1997. They both used magnetic
resonance. One used blood tagging, but they were not specifically
analyzing these types of conduits. In Dr Gundry’s article, respira-
tory variation was discussed in terms of its effects on the flow, and
I personally share your concern in terms of the loss of the me-
chanical advantage, the hydrodynamics of the stiff rigid tube.
However, according to Gundry’s article, some augmentation is
provided by respiratory variation that is easily transmitted to the
wall of that tunnel and might offset some of the mechanical energy
losses that you get with a nonrigid structure. Beyond that, I do not
have a good answer.
Woods et al Surgery for Congenital Heart Disease
The Journal of Thoracic and Cardiovascular Surgery ● Volume 125, Number 3 471
CH
D
